Piramal Pharma to acquire remaining 26% stake in Yapan Bio
With the acquisition, Piramal will fully embed Yapan’s advanced large molecule capabilities into its integrated service offering
Browse Desi NewsWith the acquisition, Piramal will fully embed Yapan’s advanced large molecule capabilities into its integrated service offering
Browse Desi NewsLoading Desi News